Medartis Group has acquired the remaining 53% of KeriMedical for CHF 99 million in cash, consolidating its position in the hand and wrist surgical market following the FDA approval of KeriMedical's TOUCH prosthesis.

Information on the Target

KeriMedical, founded in 2016 and headquartered in Geneva, Switzerland, specializes in developing and marketing a wide range of implants specifically for hand and wrist surgery. The company comprises a dedicated team of around 150 employees who possess extensive knowledge in orthopaedic surgery, with expertise spanning design, manufacturing, quality assurance, marketing, and product promotion. KeriMedical collaborates closely with a panel of distinguished surgeons both in France and internationally, leveraging their clinical and medical insights to drive the development and validation of new surgical solutions.

Industry Overview in Switzerland

The medical device industry in Switzerland is known for its innovative approaches and high-quality standards, propelling it to be one of the leading hubs for medical technology in Europe. With more than 1,200 companies operating within the sector, it is responsible for producing a variety of products that cater to both local and international markets. Furthermore, the industry benefits from substantial investment in research and development by both public and private sectors, fostering a culture of innovation.

Switzerland’s robust regulatory environment is characterized by stringent compliance requirements established by institutions like Swissmedic, which enhances the credibility and safet